Navigation Links
Start of Phase II Study for Intranasal, Seasonal Influenza Vaccine deltaFLU
Date:1/13/2010

The vaccine is administered as nasal spray instead of being injected. It is produced in cultured cells (Vero cells). This process permits automated production in bioreactors and can easily be scaled in line with the respective demand.

"Our new generation of live attenuated vaccines offers optimized effectiveness and combines high safety and maximum efficiency," explains Andrej Egorov, Vice President Research at AVIR Green Hills and one of the leading experts on live attenuated influenza vaccines.

Plans for the future

In 2010, AVIR Green Hills Biotechnology plans to run another clinical phase II study in Vienna to test the seasonal vaccine H1N1 in persons above age 65. Other studies in the pipeline are those for a monovalent H3N2 and B vaccine, which will be followed by a study for the trivalent vaccine H1N1, H3N2 and B.

In the first quarter of 2010, AVIR Green Hills Biotechnology expects to have the data from the completed phase I study for the pandemic H5N1 vaccine deltaFLU, which was also carried out at the Department of Clinical Pharmacology at the Vienna General Hospital.

AVIR Green Hills Biotechnology AG

AVIR Green Hills Biotechnology is a biopharmaceutical company based in Vienna, Austria. It was founded in 2002 and currently has a staff of 50 employees. The company's core competence is the development of innovative vaccines against viral infections and cancer.

The deltaFLU development is supported by two research projects funded by the European Union in the 6th framework program (projects FLUVACC and Intranasal H5 Vaccine). These projects led by AVIR Green Hills Biotechnology combine expertise of a renowned international consortium comprising national and international research partners.

    Contact: Isolde Bergmann

'/>"/>
SOURCE AVIR Green Hills Biotechnology AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)
2. JumpStart Invests in Checkpoint Surgical
3. Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity
4. Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
5. Dong-A PharmTech Co., Ltd. Announces Start of Phase III Trials for Udenafil, Its New Erectile Dysfunction Drug Under Development
6. AMT Starts Development LPLChip(TM) With Progenika
7. American Association for Homecare Proposes Strong Anti-Fraud Measures in Medicare, Applauds HHS Testimony Today That Pledges to "Stop Fraud Before it Starts"
8. Patients who Participated in Pleio GoodStart(TM) Refilled 30% Sooner and 40% More, Averaging 2 Additional Rx Refills per Patient
9. R-Tech Ueno Starts Early Phase II Clinical Trial for RK-023
10. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial
11. Cytopias CYT387 Receives FDA Clearance to Start US Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... BALTIMORE and LONDON , Aug. 28, ... volunteers in the UK, The Gambia and ... of an series of safety trials of potential vaccines aimed at ... the current outbreak in West Africa . ... US National Institutes of Health (NIH) and GlaxoSmithKline, are to be ...
(Date:8/28/2014)... CHARLOTTE, N.C. , Aug. 28, 2014 /PRNewswire/ ... innovation marketplace, today announced a worldwide search for ... of the senior population.  Promising ideas uncovered through ... presented to leading medical device manufacturers and healthcare ... to improve the lives of individuals age 65 ...
(Date:8/28/2014)... 28, 2014 According to a ... Identification (RFID) Market (Tags, Readers, Middleware, Printers and Cabinets) ... Forecast, 2014 - 2020" the global radiofrequency identification (RFID) ... and is expected to grow at a CAGR of ... value of USD 5.3 billion in 2020. ...
Breaking Medicine Technology:Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5
... 16, 2010 See video from Siemens Corporation ... Say so-long to the days of black ... to MRI and PET, medical imaging is faster, ... way medicine is practiced. Thanks to years of ...
... Unsustainable Medicare reimbursement rates for home medical equipment ... providers will occur as a result of Medicare,s bidding ... nine of the largest metropolitan areas in the U.S. ... Dallas-Fort Worth, Kansas City, Miami, Orlando, Pittsburgh, and Riverside, ...
Cached Medicine Technology:VIDEO from Siemens Corporation Available on thenewsmarket.com: Amazing Medical Images: Diagnosing in the Digital Age 2Problems Emerge in Competitive Bidding Pricing Scheme for Home Medical Equipment; Economists Predict the Program Will Fail 2Problems Emerge in Competitive Bidding Pricing Scheme for Home Medical Equipment; Economists Predict the Program Will Fail 3
(Date:8/28/2014)... A subset of patients with stage III colon ... therapy, according to a new study in ... the American Gastroenterological Association. , When added to the ... irinotecan therapy improved overall survival rates for patients with ... in about 10 to 20 percent of colorectal cancers. ...
(Date:8/28/2014)... over who identify themselves as ,old, feel worse about ... have lower value than younger age groups. , New ... ,Being old and ill, across different countries: social status, ... from the European Social Survey. Respondents, who were all ... health., The researchers found that those living in societies ...
(Date:8/28/2014)... Manchester scientists are working out how to safely increase ... potentially offering improved local control and survival. , Standard ... a combination of radiotherapy and chemotherapy. Traditionally this is ... may not always be enough to stop tumour growth. ... the cancerous tissue varies between patients and depends on ...
(Date:8/28/2014)... 2014 Vaccine market - the once ... among other healthcare industry sectors and sub-circles in the ... vaccine with respect to evolving and spreading infectious diseases. ... an improved understanding for a well-balanced life and improved ... has led to new opportunities for manufacturing novel preventive ...
(Date:8/28/2014)... August 28, 2014 AmeriPride Services, a ... today announced the launch of its new Customer Portal, ... even easier and more convenient for customers. The industry-leading ... and better communicate with the company. , Features of ... Access, download and pay bills online ...
Breaking Medicine News(10 mins):Health News:Drug shows promise for subset of stage III colon cancer patients 2Health News:Research demonstrates potential method to better control lung cancer using radiotherapy 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 3Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3
... The Medicare drug program is on its last lap of seeking ... of the plans to rest// with three major insurance players. ... with AARP as its official endorsers and a financial agreement with ... for the drug program by Medicare. ,80 companies have ...
... have been found to be alive in America today. ... management of the disease. // ,However it has ... do suffer from debilitating fatigue making normal activities of life ... California at Los Angeles found that not all survivors suffer ...
... included bestowing nurses and pharmacists with the right to ... and pharmacists can undertake extra training in order to ... to tonsillitis. ,Many nurses already run their ... prescribe drugs even for long-term conditions such as asthma ...
... action against smoking in Scotland, it would stop sales of tobacco ... it. ,Ministers have not decided whether to back the ... determination to reduce smoking rates in Scotland. ,In the ... a member of the expert group, "Smoking is far worse than ...
... non-typical sleep times has the ability to improve an ... Sleep Medicine at Brigham and Women’s Hospital and Harvard ... in order to find out the effectiveness of melatonin. ... travelers with jet lag. br> ,The findings appear in ...
... say that percutaneous image-guided biopsy is of a great ... accurately// diagnosing and predicting clinical outcomes. The researchers arrived ... in 126 patients. They found that the biopsy results ... who were to undergo surgery, tumor ablation, chemotherapy or ...
Cached Medicine News:Health News:Breast Cancer Survivors Growing in Numbers 2Health News:Melatonin Can Help Nighttime Workers Sleep 2Health News:Melatonin Can Help Nighttime Workers Sleep 3Health News:Image-Guided Biopsy Can Alter Clinical Decisions In Kidney Patients 2
Used for the introduction of catheters, balloons and other vascular devices....
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Sheath Introducer featuring patented SLIX Valve, rotating collar, kink-resistant cannula and atraumatic tip transitions....
The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3....
Medicine Products: